These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 8050136)

  • 1. Determinants of clinical outcome and survival in acromegaly.
    Rajasoorya C; Holdaway IM; Wrightson P; Scott DJ; Ibbertson HK
    Clin Endocrinol (Oxf); 1994 Jul; 41(1):95-102. PubMed ID: 8050136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing mortality in acromegaly.
    Holdaway IM; Rajasoorya RC; Gamble GD
    J Clin Endocrinol Metab; 2004 Feb; 89(2):667-74. PubMed ID: 14764779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure.
    Sheaves R; Jenkins P; Blackburn P; Huneidi AH; Afshar F; Medbak S; Grossman AB; Besser GM; Wass JA
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):407-13. PubMed ID: 8959078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of morbidity and mortality in acromegaly: an Italian survey.
    Arosio M; Reimondo G; Malchiodi E; Berchialla P; Borraccino A; De Marinis L; Pivonello R; Grottoli S; Losa M; Cannavò S; Minuto F; Montini M; Bondanelli M; De Menis E; Martini C; Angeletti G; Velardo A; Peri A; Faustini-Fustini M; Tita P; Pigliaru F; Borretta G; Scaroni C; Bazzoni N; Bianchi A; Appetecchia M; Cavagnini F; Lombardi G; Ghigo E; Beck-Peccoz P; Colao A; Terzolo M;
    Eur J Endocrinol; 2012 Aug; 167(2):189-98. PubMed ID: 22596288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocysteine levels in acromegaly patients.
    Hekimsoy Z; Ozmen B; Ulusoy S
    Neuro Endocrinol Lett; 2005 Dec; 26(6):811-4. PubMed ID: 16380700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative radiotherapy in acromegaly is effective in reducing GH concentration to safe levels.
    Biermasz NR; Dulken HV; Roelfsema F
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):321-7. PubMed ID: 10971449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transsphenoidal adenomectomy for growth hormone-secreting pituitary adenomas in acromegaly: outcome analysis and determinants of failure.
    Tindall GT; Oyesiku NM; Watts NB; Clark RV; Christy JH; Adams DA
    J Neurosurg; 1993 Feb; 78(2):205-15. PubMed ID: 8421204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The outcome of surgery for acromegaly: the need for a specialist pituitary surgeon for all types of growth hormone (GH) secreting adenoma.
    Lissett CA; Peacey SR; Laing I; Tetlow L; Davis JR; Shalet SM
    Clin Endocrinol (Oxf); 1998 Nov; 49(5):653-7. PubMed ID: 10197082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly.
    Holdaway IM; Bolland MJ; Gamble GD
    Eur J Endocrinol; 2008 Aug; 159(2):89-95. PubMed ID: 18524797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
    Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS
    Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry.
    Fieffe S; Morange I; Petrossians P; Chanson P; Rohmer V; Cortet C; Borson-Chazot F; Brue T; Delemer B;
    Eur J Endocrinol; 2011 Jun; 164(6):877-84. PubMed ID: 21464140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of cardiac disease in newly diagnosed patients with acromegaly: results of a 10 year survey study.
    Colao A; Pivonello R; Grasso LF; Auriemma RS; Galdiero M; Savastano S; Lombardi G
    Eur J Endocrinol; 2011 Nov; 165(5):713-21. PubMed ID: 21868601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
    Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of cardiovascular disease in acromegalic patients treated by external pituitary irradiation.
    Baldwin A; Cundy T; Butler J; Timmis AD
    Acta Endocrinol (Copenh); 1985 Jan; 108(1):26-30. PubMed ID: 3969807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acromegaly with normal IGF-1 levels probably due to poorly controlled diabetes mellitus.
    Arihara Z; Sakurai K; Yamada S; Murakami O; Takahashi K
    Tohoku J Exp Med; 2008 Dec; 216(4):325-9. PubMed ID: 19060447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GH and mortality in acromegaly.
    Sheppard MC
    J Endocrinol Invest; 2005; 28(11 Suppl International):75-7. PubMed ID: 16625851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities in glucose homeostasis in acromegaly. Does the prevalence of glucose intolerance depend on the level of activity of the disease and the duration of the symptoms?
    Stelmachowska-Banaś M; Zdunowski P; Zgliczyński W
    Endokrynol Pol; 2009; 60(1):20-4. PubMed ID: 19224501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of primary somatostatin analogue therapy and pituitary adenomectomy on survival in patients with acromegaly: a retrospective cohort study.
    Bogazzi F; Colao A; Rossi G; Lombardi M; Urbani C; Sardella C; Iannelli A; Scattina I; Manetti L; Del Sarto S; Pivonello R; Grasso LF; Lupi I; Auriemma RS; Lombardi G; Martino E
    Eur J Endocrinol; 2013 Sep; 169(3):367-76. PubMed ID: 23828855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep apnoea in treated acromegaly: relative frequency and predisposing factors.
    Rosenow F; Reuter S; Deuss U; Szelies B; Hilgers RD; Winkelmann W; Heiss WD
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):563-9. PubMed ID: 8977753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Liege Acromegaly Survey (LAS): a new software tool for the study of acromegaly.
    Petrossians P; Tichomirowa MA; Stevenaert A; Martin D; Daly AF; Beckers A
    Ann Endocrinol (Paris); 2012 Jun; 73(3):190-201. PubMed ID: 22682917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.